Locally advanced colon cancer: Evaluation of current clinical practice and treatment outcomes at the population level

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 15, Issue 2, 2017, Pages 181-190

  Klaver, Charlotte E L ^a   Gietelink, Lieke ^b,c   Bemelman, Willem A ^a   Wouters, Michel W J M ^c,d   Wiggers, Theo ^e   Tollenaar, Rob A E M ^b,c   Tanis, Pieter J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Dutch Institute for Clinical Auditing   (Netherlands)

^d ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ABSCESS; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; BLEEDING; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL OUTCOME; CLINICAL PRACTICE; COLON CANCER; CONTROLLED STUDY; ELECTIVE SURGERY; FECAL PERITONITIS; FEMALE; HIGH VOLUME HOSPITAL; HOSPITAL MORTALITY; HUMAN; LENGTH OF STAY; LOW VOLUME HOSPITAL; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OBSTRUCTION; PERFORATION; PERITONITIS; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; PREOPERATIVE COMPLICATION; PROTOCOL COMPLIANCE; VERY ELDERLY; CLINICAL AUDIT; COLONIC NEOPLASMS; HEALTH CARE QUALITY; INTERDISCIPLINARY COMMUNICATION; MIDDLE AGED; NEOADJUVANT THERAPY; NETHERLANDS; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINE; PROCEDURES; PROGNOSIS; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; ELECTIVE SURGICAL PROCEDURES; FEMALE; GUIDELINE ADHERENCE; HOSPITAL MORTALITY; HUMANS; INTERDISCIPLINARY COMMUNICATION; MALE; MEDICAL AUDIT; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; NETHERLANDS; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; QUALITY OF HEALTH CARE; TREATMENT OUTCOME;

EID: 85016209848     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2017.0019     Document Type: Article

References (33)

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2014;136:E359-386.
2. Izbicki JR, Hosch SB, Knoefel WT, et al. Extended resections are beneficial for patients with locally advanced colorectal cancer. Dis Colon Rectum 1995;38:1251-1256.
3. Saha AK, Smith KJE, Sue-Ling H, et al. Prognostic factors for survival after curative resection of Dukes' B colonic cancer. Colorectal Dis 2011;13:1390-1394.
4. Edge S, Byrd DR, Compton CC, et al, eds. AJCC Cancer Staging Manual, 7th ed. New York, NY: Springer; 2010.
5. Larkin JO, O'Connell PR. Multivisceral resection for T4 or recurrent colorectal cancer. Dig Dis 2012;30(Suppl 2):96-101.
6. Foxtrot Collaborative Group. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. Lancet Oncol 2012;13:1152-1160.
7. van Leersum NJ, Snijders HS, Wouters MW, et al. Evaluating national practice of preoperative radiotherapy for rectal cancer based on clinical auditing. Eur J Surg Oncol 2013;39:1000-1006.
8. Kolfschoten NE, Marang van de Mheen PJ, Gooiker GA, et al. Variation in case-mix between hospitals treating colorectal cancer patients in the Netherlands. Eur J Surg Oncol 2011;37:956-963.
9. Amri R, Bordeianou LG, Sylla P, Berger DL. Association of radial margin positivity with colon cancer. JAMA Surg 2015;150:890-898.
10. Khan MA, Hakeem AR, Scott N, Saunders RN. Significance of R1 resection margin in colon cancer resections in the modern era. Colorectal Dis 2015;17:943-953.
11. Elnahas A, Sunil S, Jackson TD, et al. Laparoscopic versus open surgery for T4 colon cancer: evaluation of margin status. Surg Endosc 2016;30:1491-1496.
12. Campos FG, Calijuri-Hamra MC, Imperiale AR, et al. Locally advanced colorectal cancer: results of surgical treatment and prognostic factors. Arq Gastroenterol 48:270-275.
13. Gezen C, Kement M, Altuntas YE, et al. Results after multivisceral resections of locally advanced colorectal cancers: an analysis on clinical and pathological t4 tumors. World J Surg Oncol 2012;10:39.
14. Hoffmann M, Phillips C, Oevermann E, et al. Multivisceral and standard resections in colorectal cancer. Langenbecks Arch Surg 2012;397:75-84.
15. Gietelink L, Henneman D, van Leersum NJ, et al. The influence of hospital volume on circumferential resection margin involvement: results of the Dutch Surgical Colorectal Audit. Ann Surg 2016;263:745-750.
16. Govindarajan A, Coburn NG, Kiss A, et al. Population-based assessment of the surgical management of locally advanced colorectal cancer. J Natl Cancer Inst 2006;98:1474-1481.
17. Cukier M, Smith AJ, Milot L, et al. Neoadjuvant chemoradiotherapy and multivisceral resection for primary locally advanced adherent colon cancer: a single institution experience. Eur J Surg Oncol 2012;38:677-682.
18. Mohan HM, Evans MD, Larkin JO, et al. Multivisceral resection in colorectal cancer: a systematic review. Ann Surg Oncol 2013;20:2929-2936.
19. Gebhardt C, Meyer W, Ruckriegel S, Meier U. Multivisceral resection of advanced colorectal carcinoma. Langenbecks Arch Surg 1999;384:194-199.
20. Darakhshan A, Lin BPFC, Chan C, et al. Correlates and outcomes of tumor adherence in resected colonic and rectal cancers. Ann Surg 2008;247:650-658.
21. Cirocchi R, Partelli S, Castellani E, et al. Right hemicolectomy plus pancreaticoduodenectomy vs partial duodenectomy in treatment of locally advanced right colon cancer invading pancreas and/or only duodenum. Surg Oncol 2014;23:92-98.
22. Zhang J, Leng J, Qian H, et al. En bloc pancreaticoduodenectomy and right colectomy in the treatment of locally advanced colon cancer. Dis Colon Rectum 2013;56:874-880.
23. Croner RS, Merkel S, Papadopoulos T, et al. Multivisceral resection for colon carcinoma. Dis Colon Rectum 2009;52:1381-1386.
24. Stojadinovic A, Nissan A, Wainberg Z, et al. Time-dependent trends in lymph node yield and impact on adjuvant therapy decisions in colon cancer surgery: an international multi-institutional study. Ann Surg Oncol 2012;19:4178-4185.
25. Scott N, Jamali A, Verbeke C, et al. Retroperitoneal margin involvement by adenocarcinoma of the caecum and ascending colon: what does it mean? Color Dis 2008;10:289-293.
26. Vignali A, Ghirardelli L, Di Palo S, et al. Laparoscopic treatment of advanced colonic cancer: a case-matched control with open surgery. Color Dis 2013;15:944-948.
27. Shukla PJ, Trencheva K, Merchant C, et al. Laparoscopic resection of T4 colon cancers: is it feasible? Dis Colon Rectum 2015;58:25-31.
28. Arredondo J, Pastor C, Baixauli J, et al. Preliminary outcome of a treatment strategy based on perioperative chemotherapy and surgery in patients with locally advanced colon cancer. Colorectal Dis 2013;15:552-557.
29. Karoui M, Rullier A, Luciani A, et al. Neoadjuvant FOLFOX 4 versus FOLFOX 4 with cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial - the PRODIGE 22 - ECKINOXE trial. BMC Cancer 2015;15:511.
30. Hallet J, Zih FS, Lemke M, et al. Neo-adjuvant chemoradiotherapy and multivisceral resection to optimize R0 resection of locally recurrent adherent colon cancer. Eur J Surg Oncol 2014;40:706-712.
31. van Santvoort HC, Braam HJ, Spekreijse KR, et al. Peritoneal carcinomatosis in t4 colorectal cancer: occurrence and risk factors. Ann Surg Oncol 2014;21:1686-1691.
32. Huh JW, Kim HR. The feasibility of laparoscopic resection compared to open surgery in clinically suspected T4 colorectal cancer. J Laparoendosc Adv Surg Tech A 2012;22:463-467.
33. Kim IY, Kim BR, Kim YW. The short-term and oncologic outcomes of laparoscopic versus open surgery for T4 colon cancer. Surg Endosc 2016;30:1508-1518.